KOSDAQ · Healthcare · ₩39B
₩2,745-0.36%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.4% · as of 26.09.11
Among 15 신약 개발 peers
Quarterly Revenue Growth
“이번 분기는 검사 수요가 늘며 수익성 개선의 기반을 다진 때예요.”
In the company's words · 2026 2분기 filing